
0:00
59:27
In Part 2 of our ESMO 2026 Highlights series, Dr. Stephen Liu and Dr. Narjust Florez welcome Dr. Xiao-Rong Dong, Dr. Yi-Long Wu, and Dr. Chantal Decroisette to discuss three important clinical trials: SAFFRON, SANOVO, and PERSEE. The conversations explore emerging strategies for targeting MET in EGFR-mutated non-small cell lung cancer, advances in first-line immunotherapy, and the potential implications of these findings for clinical practice.
Xiao-Rong Dong, MD, PhD ([email protected])
Professor, Chief Physician and Doctoral Supervisor
Director, Department of Thoracic Oncology
Cancer Center of Union Hospital, Huazhong University of Science and Technology
No Social
Chantal Decroisette, MD
Thoracic Oncologist, Medical Oncology Department
Centre Léon Bérard, Lyon
No Social
Yi-Long Wu, MD
Professor, Guangdong Lung Cancer Institute
Guangdong Provincial People’s Hospital
Social: @ThomasW35874311
Flere episoder fra "Lung Cancer Considered"



Gå ikke glip af nogen episoder af “Lung Cancer Considered” - abonnér på podcasten med gratisapp GetPodcast.








